{
  "trial_id": "NCT04528576",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age \u2265 18 yrs",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Moderate-to-severe (3+) or severe (4+) mitral valve regurgitation on transthoracic or transesophageal echocardiography, and confirmed by echocardiographic core laboratory",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "The patient is on optimal guideline directed medical therapy for heart failure and remains symptomatic.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "High or prohibitive surgical risk as defined by either Society for Thoracic Surgery Risk Calculator score for valve replacement \u2265 8 points; or STS score for valve repair \u2265 6 points , prohibitive risk as determined by the clinical judgement of the site heart team, including a cardiac surgeon experienced in mitral valve surgery and a cardiologist experience in mitral valve disease, due to the presence of one or more documented surgical risk factors.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Anatomically suitable for mitral valve repair and can be treated by Dragonfly confirmed by both site investigators, echocardiographic core laboratory, and the eligibility committee.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Transseptal catheterization and femoral vein access is determined to be feasible",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Life expectancy \u2265 12 months",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "The subject or the subject's legal representative has been informed of the nature of the trial, willing to accept the experimental tests and follow-ups, and has provided written informed consent",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "History of heart transplantation, prior mitral valve replacement surgery. or transcatheter mitral valve procedure;",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Leaflet anatomy which may preclude Dragonfly-MTM implantation and position, as judged by the site investigators and confirmed by the echocardiographic core laboratory and eligibility committee",
      "label": "unknown",
      "evidence": "quote"
    }
  ],
  "notes": "34 year old woman with Marfan's syndrome and known severe mitral valve prolapse with regurgitation. She remains symptomatic and is now prepared to undergo mitral valve repair/replacement surgery.",
  "_meta": {
    "topic_id": "12",
    "trial_id": "NCT04528576",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}